Novacyt S.A.
NCYT.L · LSE
6/30/2025 | 3/31/2025 | 12/31/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.03 | 0.02 | 0.00 | 0.00 |
| FCF Yield | -9.50% | -11.17% | -2.82% | -14.71% |
| EV / EBITDA | -3.31 | -4.65 | -0.97 | -0.13 |
| Quality | ||||
| ROIC | -11.00% | -5.43% | -10.87% | -10.14% |
| Gross Margin | 32.61% | 66.45% | 17.49% | 32.31% |
| Cash Conversion Ratio | 1.65 | 0.86 | 0.02 | 0.51 |
| Growth | ||||
| Revenue 3-Year CAGR | -33.53% | -44.09% | -44.43% | -45.58% |
| Free Cash Flow Growth | 0.00% | -186.15% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 3.30 | 7.03 | 1.09 | 2.25 |
| Interest Coverage | -20.35 | 0.00 | -22.05 | -22.71 |
| Efficiency | ||||
| Inventory Turnover | 0.55 | 0.46 | 3.34 | 2.31 |
| Cash Conversion Cycle | 124.98 | 178.49 | 57.85 | 160.74 |